TITLE

Topiramate-associated bilateral anterior uveitis and angle closure glaucoma

AUTHOR(S)
Acharya, Nibedita; Nithyanandam, Suneetha; Kamat, Sripathi
PUB. DATE
November 2010
SOURCE
Indian Journal of Ophthalmology;Nov2010, Vol. 58 Issue 6, p557
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: A case series," by Senthil S. in the November to December 2010 issue.
ACCESSION #
55249675

 

Related Articles

  • Letter to the Editor: 1H, 15N, and 13C resonance assignments and secondary structure of the Ssh10b from hyperthermophilic archaeon Sulfolobus shibatae. Yufeng Tong; Qiu Cui; Yingang Feng; Li Huang; Jinfeng Wang // Journal of Biomolecular NMR;Apr2002, Vol. 22 Issue 4, p385 

    Presents a letter to the editor on resonance assignments and secondary structure of the Ssh10b from hyperthermophilic archaeon Sulfolobus shibatae.

  • Found useful in treating ailments.  // FDA Consumer;Oct84, Vol. 18 Issue 8, p8 

    Nearly 50 years ago, sulfonamides were hailed as `wonder drugs.' They remain the drugs of choice in many situations, and they've led to development of other drugs. Now further research has proved derivatives useful in treating infections, diabetes, glaucoma, epilepsy, heart failure, and high...

  • Scientific evidence versus therapeutic demand: the introduction of the sulfonamides revisited. Lerner, Barron H.; Lerner, B H // Annals of Internal Medicine;8/15/91, Vol. 115 Issue 4, p315 

    Because of recent changes in Federal Food and Drug Administration (FDA) regulations, new medications may now be marketed before completion of rigorous controlled testing. In order to understand the ramifications of this development, it is instructive to recall the introduction of the...

  • Anticancer and Antiviral Sulfonamides. A. Scozzafava; T. Owa; A. Mastrolorenzo; C.T. Supuran // Current Medicinal Chemistry;Jun2003, Vol. 10 Issue 11, p925 

    The sulfonamides constitute an important class of drugs, with several types of pharmacological agents possessing antibacterial, anti- carbonic anhydrase, diuretic, hypoglycemic and antithyroid activity among others. A large number of structurally novel sulfonamide derivatives have ultimately...

  • sulfonamide.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2237 

    A definition of the term "sulfonamide," which refers to any group of compounds that comprises of amides of sulfanilic acid derived from the sulfanilamide parent compound, is presented.

  • sulfonamide:. Schlegel, Rolf H. J. // Encyclopedic Dictionary of Plant Breeding & Related Subjects;2003, p402 

    A definition of the term "sulfonamide" is presented, which refers to a chemical having a bacteriostatic effect.

  • Effects on human thyroid function of sulphonamide and trimethoprim combination drugs. Cohen, Howard N.; Beastall, G.H.; Ratcliffe, W.A.; Gray, C.; Watson, I.D.; Thomson, J.A. // British Medical Journal;9/6/1980, Vol. 281 Issue 6241, p646 

    Examines the effects of human thyroid function of sulphonamide and trimethoprim combination drugs in Great Britain. Calculation of thyroid-stimulating hormone concentration and free thyroxine index; Determination of serum T3 and T4 results; Role of sulphonamide and trimethoprim combination...

  • sulfamethoxazole:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p207 

    A definition of the term "sulfamethaxole," which refers to a sulfonamide appearing as a white to off-white crystalline powder, is presented.

  • TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients. Lasho, T. L.; Tefferi, A.; Hood, J. D.; Verstovsek, S.; Gilliland, D. G.; Pardanani, A. // Leukemia (08876924);Sep2008, Vol. 22 Issue 9, p1790 

    A letter to the editor is presented about the examination of the inhibitory effect of TG101348, a JAK2-selective antagonist, on ex vivo hematopoietic colony growth in myeloproliferative disorder patients.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics